n 2008, in response to the identification of patients with “chronic eosinophilic leukemia” or “hypereosinophilic syndrome” who carried recurrent tyrosine kinase fusion genes involving PDGFRA, PDGFRB, or FGFR1, the World Health Organization classification of myeloid neoplasms included a new category termed “Myeloid/lymphoid neoplasms (MLN) with eosinophilia and rearrangements of PDGFRA, PDGFRB, or FGFR1”
Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group / Shomali, William; Colucci, Philomena; George, Tracy I; Kiladjian, Jean-Jacques; Langford, Cheryl; Patel, Jay L; Reiter, Andreas; Vannucchi, Alessandro M; Gotlib, Jason. - In: LEUKEMIA. - ISSN 0887-6924. - ELETTRONICO. - 37:(2023), pp. 981-987. [10.1038/s41375-023-01859-3]
Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group
Vannucchi, Alessandro M;
2023
Abstract
n 2008, in response to the identification of patients with “chronic eosinophilic leukemia” or “hypereosinophilic syndrome” who carried recurrent tyrosine kinase fusion genes involving PDGFRA, PDGFRB, or FGFR1, the World Health Organization classification of myeloid neoplasms included a new category termed “Myeloid/lymphoid neoplasms (MLN) with eosinophilia and rearrangements of PDGFRA, PDGFRB, or FGFR1”File | Dimensione | Formato | |
---|---|---|---|
Comprehensive response criteria for myeloid lymphoid.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
658.85 kB
Formato
Adobe PDF
|
658.85 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.